Debio 1143 in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and platinum-refractory epithelial ovarian cancer (EOC). Preliminary results of a Phase I dose-escalation s

Affiliation auteurs!!!! Error affiliation !!!!
TitreDebio 1143 in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and platinum-refractory epithelial ovarian cancer (EOC). Preliminary results of a Phase I dose-escalation s
Type de publicationJournal Article
Year of Publication2014
AuteursLe Tourneau C., Ray-Coquard I., Isambert N., Gomez-Roca C.A, Cassier P., Sablin M.P, Ruits E., Gavillet B., Zanna C., Fumuleau P., Delord J.P
JournalEUROPEAN JOURNAL OF CANCER
Volume50
Pagination146
Date PublishedNOV
Type of ArticleMeeting Abstract
ISSN0959-8049
DOI10.1016/S0959-8049(14)70570-2